Bullish
$OTIC I reached out to company management on the 3 current pipeline trials this morning. They responded that they are still working within the stated timelines for all 3 trials - OTIVIDEX, OTO-313, and OTO-413, which is very positive to hear. They were also ahead of the curve to ensure the clinical team is still working and remotely able to continue as needed. In other words, they are not impacted CA Governor’s new directives.
  • 9
  • 2